MINDMAZE THERAPEUTICS HOLDING SA (SW:MMTX) — Stock Price
MINDMAZE THERAPEUTICS HOLDING SA (SW:MMTX) is currently trading at CHF0.24 CHF, down 1.66% today. Over the past 52 weeks, shares have ranged between CHF0.15 and CHF2.77. This page tracks MINDMAZE THERAPEUTICS HOLDING SA's live share price on the SW exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see MMTX market cap.
MINDMAZE THERAPEUTICS HOLDING SA (MMTX) Stock Price Chart — Daily History & Trading Volume
The chart below tracks MINDMAZE THERAPEUTICS HOLDING SA's daily closing share price and trading volume on the SW exchange over the past year, giving a clear view of recent price momentum and liquidity.
MINDMAZE THERAPEUTICS HOLDING SA Income Statement — Revenue, Profit & Earnings by Year
MINDMAZE THERAPEUTICS HOLDING SA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 |
|---|---|---|
| Total Revenue | CHF642.00K | CHF0.00 |
| Cost of Revenue | CHF51.00K | CHF0.00 |
| Gross Profit | CHF591.00K | CHF0.00 |
| Research & Development | CHF5.29 Million | CHF0.00 |
| SG&A | CHF5.82 Million | CHF2.00K |
| Total Operating Expenses | CHF11.16 Million | CHF2.00K |
| Operating Income | CHF-10.52 Million | CHF-2.00K |
| EBITDA | — | — |
| EBIT | — | — |
| Interest Expense | CHF266.00K | CHF0.00 |
| Income Before Tax | CHF-9.91 Million | CHF-1.00K |
| Income Tax Expense | — | — |
| Net Income | CHF-9.91 Million | CHF-1.00K |
MINDMAZE THERAPEUTICS HOLDING SA Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes MINDMAZE THERAPEUTICS HOLDING SA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 |
|---|---|---|
| Total Assets | CHF51.53 Million | CHF93.00K |
| Total Current Assets | CHF13.15 Million | CHF0.00 |
| Cash & Equivalents | — | — |
| Short-term Investments | — | — |
| Net Receivables | CHF1.02 Million | CHF0.00 |
| Inventory | CHF1.14 Million | CHF0.00 |
| Property, Plant & Equipment | — | — |
| Goodwill | CHF28.40 Million | CHF0.00 |
| Total Liabilities | CHF13.19 Million | CHF7.00K |
| Total Current Liabilities | CHF10.93 Million | CHF2.00K |
| Long-term Debt | — | — |
| Net Debt | — | — |
| Total Stockholder Equity | CHF38.34 Million | CHF86.00K |
| Retained Earnings | CHF-10.67 Million | CHF-14.00K |
MINDMAZE THERAPEUTICS HOLDING SA Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how MINDMAZE THERAPEUTICS HOLDING SA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 |
|---|---|---|
| Operating Cash Flow | CHF-7.21 Million | CHF-3.00K |
| Capital Expenditures | CHF22.00K | CHF0.00 |
| Free Cash Flow | CHF-7.23 Million | CHF-3.00K |
| Investing Cash Flow | — | — |
| Financing Cash Flow | — | — |
| Dividends Paid | — | — |
| Stock-Based Compensation | — | — |
| Depreciation | CHF1.64 Million | CHF0.00 |
| Change in Cash | CHF9.45 Million | CHF-5.00K |
MINDMAZE THERAPEUTICS HOLDING SA Earnings History — EPS Actual vs. Analyst Estimates
Track MINDMAZE THERAPEUTICS HOLDING SA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 14, 2025 | -0.36 | 0.00 | — |
| Apr 10, 2025 | -0.50 | 0.00 | — |
| Apr 30, 2024 | -3.36 | 0.00 | — |
| Apr 14, 2023 | -0.01 | 0.00 | — |
| Sep 15, 2022 | -0.01 | 0.00 | — |
| Mar 31, 2022 | -0.01 | 0.00 | — |
| Sep 24, 2021 | 0.00 | 0.00 | — |
| Apr 15, 2021 | -0.01 | 0.00 | — |